What pancreatic enzyme laboratory tests should be ordered to assess for acute pancreatitis and chronic exocrine pancreatic insufficiency?

Pancreatic Enzyme Laboratory Tests

For acute pancreatitis, order serum lipase alone (not amylase), and for chronic exocrine pancreatic insufficiency, order fecal elastase-1 as the initial test.

Acute Pancreatitis Diagnosis

Primary Enzyme Test

• Order serum lipase only - this is the gold standard for diagnosing acute pancreatitis 1
• Diagnostic threshold: ≥3 times the upper limit of normal 1
• Lipase offers superior sensitivity (79%) and specificity (89%) compared to amylase (72% and 93% respectively) 1
• Lipase remains elevated longer (8-14 days vs 3-7 days for amylase), providing a larger diagnostic window 1

Why Not Amylase?

Amylase is less specific because it's also secreted by salivary glands, small intestine, ovaries, adipose tissue, and skeletal muscles 1. Co-ordering both tests provides little to no increase in diagnostic accuracy and wastes resources 2. Current evidence-based guidelines recommend lipase over amylase 2.

Additional Labs for Acute Pancreatitis Context

When acute pancreatitis is confirmed, order these to assess etiology and prognosis:

For etiology determination:

• Serum triglycerides - if >1000 mg/dl (11.3 mmol/L), this confirms hypertriglyceridemia as the cause 1
• Serum calcium - to identify hypercalcemia as a cause 1

For prognostic assessment (impacts mortality/morbidity):

• C-reactive protein (CRP) on day 3 - level ≥150 mg/L predicts severe acute pancreatitis 1
• Hematocrit - >44% is an independent risk factor for pancreatic necrosis 1
• Blood urea nitrogen (BUN) - >20 mg/dl predicts mortality 1
• Procalcitonin - most sensitive for detecting pancreatic infection; low values strongly predict absence of infected necrosis 1

Chronic Exocrine Pancreatic Insufficiency (EPI)

Primary Test

Order fecal elastase-1 - this is the most appropriate initial test 3

Critical testing requirements:

• Must be performed on semi-solid or solid stool (not liquid diarrhea) 3
• Can be performed while patient is on pancreatic enzyme replacement therapy 3

Interpretation:

• <100 μg/g = good evidence of EPI 3
• 100-200 μg/g = indeterminate for EPI 3
• >200 μg/g = normal

Important Caveats

The fecal elastase-1 test has moderate specificity (82% at 100 μg/g cutoff, 69% at 200 μg/g cutoff) 4. This means:

• It performs well for screening high-risk populations (chronic pancreatitis, post-pancreatic surgery, cystic fibrosis)
• False positives can occur in lower-risk settings
• Sensitivity is better in cystic fibrosis (98%) and specificity is better in chronic pancreatitis (81%) 4

Alternative Tests (Rarely Needed)

• Fecal fat testing - rarely needed in clinical practice; requires high-fat diet during collection; quantitative testing is impractical 3, 5
• Coefficient of fat absorption (CFA) or 72-hour fecal fat excretion - gold standard but rarely performed due to complexity 4, 5
• Breath tests and direct pancreatic function tests - not widely available in the United States 3

Do NOT Use

Therapeutic trial of pancreatic enzymes is unreliable for EPI diagnosis 3 - this is a common pitfall to avoid.

Clinical Context for Testing

When to Suspect EPI (High-Risk):

• Chronic pancreatitis
• Relapsing acute pancreatitis
• Pancreatic ductal adenocarcinoma
• Cystic fibrosis
• Previous pancreatic surgery 3

Moderate-Risk Conditions:

• Celiac disease or Crohn's disease
• Previous intestinal surgery
• Long-standing diabetes mellitus
• Zollinger-Ellison syndrome 3

The distinction matters because fecal elastase-1 has better predictive value in high-risk populations 4. In lower-risk settings, interpret borderline results cautiously and consider clinical context heavily.